Seçil Demirkol Canlı

Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer

Betül Taşkoparan, Esin Gülce Seza, Seçil Demirkol Canlı et al. · Cellular Oncology · 2017 · 58 citations · Full text

Medicine, Biochemistry, Oncology +14

A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer

Seçil Demirkol Canlı, İsmail Gömceli, Murat İşbilen et al. · Journal of Cancer · 2017 · 39 citations · Full text

Medicine, Bioinformatics, Oncology +17

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide

Seyhan Türk, Can Türk, Muhammad Waqas Akbar et al. · PLoS ONE · 2020 · 24 citations · Full text

Medicine, Hematology, Oncology +14

A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer

Gürcan Tunalı, Süleyman Can Öztürk, Seçil Demirkol Canlı et al. · Breast Cancer Research · 2023 · 24 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway

Seçil Demirkol Canlı, Esin Gülce Seza, Ilir Sheraj et al. · Carcinogenesis · 2020 · 21 citations · Full text

Medicine, Genetics, Oncology +17